Lai F M, Shepherd C A, Cervoni P, Wissner A
Life Sci. 1983 Mar 7;32(10):1159-66. doi: 10.1016/0024-3205(83)90122-4.
Synthetic (+/-) 1-O-octadecyl-2-acetyl-glyceryl-3-phosphorylcholine (octadecyl-AGPC) in microgram/kg doses given intravenously effectively and potently lowered mean arterial blood pressure in conscious and anesthetized normotensive rats. The hypotensive activity was much more pronounced in the anesthetized rat than in the conscious rat. The hypotension was associated with a significant elevation in plasma renin activity (PRA). In the rat in which the hindquarters were perfused, octadecyl-AGPC given intraarterially effectively decreased the perfusion and systemic pressures in a dose-dependent manner. Pharmacological blockade with specific cholinergic, histaminergic or beta-adrenergic receptor antagonists, did not block or attenuate the octadecyl-AGPC-induced reduction in perfusion or systemic pressure. These results suggest that the hypotensive activity of octadecyl-AGPC in the normotensive rat is the result of direct vasodilation and not the result of cholinergic, histaminergic or beta-adrenergic receptor interaction.
静脉注射微克/千克剂量的合成(±)1 - O - 十八烷基 - 2 - 乙酰基 - 甘油 - 3 - 磷酸胆碱(十八烷基 - AGPC)能有效且显著降低清醒和麻醉的正常血压大鼠的平均动脉血压。麻醉大鼠的降压活性比清醒大鼠更明显。低血压与血浆肾素活性(PRA)的显著升高有关。在灌注后肢的大鼠中,动脉内给予十八烷基 - AGPC以剂量依赖性方式有效降低灌注压和全身血压。用特异性胆碱能、组胺能或β - 肾上腺素能受体拮抗剂进行药理阻断,并未阻断或减弱十八烷基 - AGPC引起的灌注压或全身血压降低。这些结果表明,十八烷基 - AGPC在正常血压大鼠中的降压活性是直接血管舒张的结果,而非胆碱能、组胺能或β - 肾上腺素能受体相互作用的结果。